Concepts (59)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Oxytocin | 2 | 2006 | 10 | 0.480 |
Why?
|
| Fetus | 2 | 2017 | 56 | 0.410 |
Why?
|
| Pregnancy | 4 | 2017 | 386 | 0.340 |
Why?
|
| Pregnancy Proteins | 1 | 2007 | 2 | 0.300 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2007 | 5 | 0.300 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2007 | 7 | 0.300 |
Why?
|
| Placenta | 1 | 2007 | 13 | 0.300 |
Why?
|
| Researcher-Subject Relations | 1 | 2006 | 2 | 0.280 |
Why?
|
| Nursing Theory | 1 | 2006 | 7 | 0.280 |
Why?
|
| Uterine Contraction | 1 | 2006 | 1 | 0.270 |
Why?
|
| Hysterotomy | 1 | 2006 | 1 | 0.270 |
Why?
|
| Obstetric Labor, Premature | 2 | 2006 | 4 | 0.270 |
Why?
|
| Papio | 2 | 2006 | 9 | 0.270 |
Why?
|
| Apoptosis | 1 | 2007 | 259 | 0.270 |
Why?
|
| Empathy | 1 | 2006 | 36 | 0.270 |
Why?
|
| Morphine | 1 | 2006 | 83 | 0.260 |
Why?
|
| Patient Selection | 1 | 2006 | 234 | 0.240 |
Why?
|
| Analgesics, Opioid | 1 | 2006 | 221 | 0.220 |
Why?
|
| Pregnancy, Animal | 1 | 2002 | 4 | 0.200 |
Why?
|
| Ideal Body Weight | 1 | 2017 | 2 | 0.150 |
Why?
|
| Pregnancy Trimester, First | 1 | 2017 | 5 | 0.150 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2017 | 9 | 0.150 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2017 | 20 | 0.150 |
Why?
|
| Pregnancy Complications | 1 | 2017 | 52 | 0.140 |
Why?
|
| Obesity | 1 | 2017 | 290 | 0.120 |
Why?
|
| Placenta Growth Factor | 1 | 2007 | 2 | 0.080 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2007 | 16 | 0.080 |
Why?
|
| Pre-Eclampsia | 1 | 2007 | 8 | 0.080 |
Why?
|
| Nicotine | 1 | 2007 | 7 | 0.080 |
Why?
|
| Neovascularization, Physiologic | 1 | 2007 | 21 | 0.080 |
Why?
|
| In Vitro Techniques | 1 | 2007 | 215 | 0.070 |
Why?
|
| Oxygen | 1 | 2007 | 86 | 0.070 |
Why?
|
| Female | 4 | 2017 | 16410 | 0.070 |
Why?
|
| Principle-Based Ethics | 1 | 2006 | 1 | 0.070 |
Why?
|
| Fetal Death | 1 | 2006 | 4 | 0.070 |
Why?
|
| Life Support Care | 1 | 2006 | 11 | 0.070 |
Why?
|
| Nursing Methodology Research | 1 | 2006 | 24 | 0.070 |
Why?
|
| Patient Dropouts | 1 | 2006 | 28 | 0.070 |
Why?
|
| Vulnerable Populations | 1 | 2006 | 24 | 0.070 |
Why?
|
| Intensive Care, Neonatal | 1 | 2006 | 34 | 0.070 |
Why?
|
| Attitude to Health | 1 | 2006 | 98 | 0.060 |
Why?
|
| Postoperative Care | 1 | 2006 | 127 | 0.060 |
Why?
|
| Adaptation, Psychological | 1 | 2006 | 142 | 0.060 |
Why?
|
| Animals | 2 | 2006 | 4637 | 0.060 |
Why?
|
| Nurse's Role | 1 | 2006 | 117 | 0.060 |
Why?
|
| Parents | 1 | 2006 | 106 | 0.060 |
Why?
|
| Attitude of Health Personnel | 1 | 2006 | 149 | 0.060 |
Why?
|
| Research Design | 1 | 2006 | 214 | 0.060 |
Why?
|
| Cystinyl Aminopeptidase | 1 | 2002 | 1 | 0.050 |
Why?
|
| Tocolytic Agents | 1 | 2002 | 1 | 0.050 |
Why?
|
| Drug Stability | 1 | 2002 | 10 | 0.050 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2002 | 4 | 0.050 |
Why?
|
| Humans | 4 | 2017 | 29811 | 0.050 |
Why?
|
| Vagina | 1 | 2017 | 49 | 0.040 |
Why?
|
| Gestational Age | 1 | 2017 | 75 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2017 | 403 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 969 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 1187 | 0.030 |
Why?
|
| Adult | 1 | 2017 | 8741 | 0.010 |
Why?
|